Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

A Trial of the Safety and Efficacy of SEP-363856 in the Treatment of Adults With Major Depressive Disorder

ClinicalTrials.gov ID: NCT05593029

Public ClinicalTrials.gov record NCT05593029. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 1, 2026, 5:36 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2/3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial of the Safety and Efficacy of Flexible Doses of SEP-363856 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Demonstrate ability of SEP-363856 to be superior to placebo as an adjunctive therapy to ADT in change from baseline in depressive symptoms (MADRS \& CGI-S) in MDD patients who had an inadequate response to prior ADT therapy.

Study identification

NCT ID
NCT05593029
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Enrollment
929 participants

Conditions and interventions

Interventions

Drug · Other

Eligibility (public fields only)

Age range
18 Years to 65 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 8, 2022
Primary completion
Nov 5, 2025
Completion
Nov 12, 2025
Last update posted
Feb 17, 2026

2022 – 2025

United States locations

U.S. sites
53
U.S. states
22
U.S. cities
48
Facility City State ZIP Site status
University of Alabama at Birmingham Birmingham Alabama 35294
Scottsdale Clinical Research Scottsdale Arizona 85260
DelSol Research Tucson Arizona 85715
Pillar Clinical Research Bentonville Arkansas 72712
ProScience Research Group Culver City California 90230
Wr-Pri, Llc Encino California 91316
Collaborative NeuroScience Research , LLC Garden Grove California 92845
Alliance Research Long Beach California 90807
ATP Clinical Research, Inc. Orange California 92868
Anderson Clinical Research Redlands California 92374
California Mental Behavioral Health Santee California 92071
Schuster Medical Research Institute SMRI Sherman Oaks California 91403
Viking Clinical Research Temecula California 92591
Collaborative Neuroscience Research LLC Torrance California 90504
Sunwise Clinical Research with is in Lafayette, CA Walnut Creek California 94596
Institute of Living Hartford Hospital Hartford Connecticut 06106
Clinical Neuroscience Solutions Inc. Jacksonville Florida 32256
K2 Medical Research Maitland Florida 32751
Central Miami Medical Institute Miami Florida 33125
Clinical Neuroscience Solutions Inc. dba CNS Healthcare Orlando Florida 32801
Combined Research Orlando Phase I-IV Orlando Florida 32807
K2 Medical Research Tampa Florida 33607
Interventional Psychiatry of Tampa Bay Tampa Florida 33629
Advanced Discovery Research LLC Atlanta Georgia 30318
Renew Health Clinical Research Snellville Georgia 30078
MetroMed Clinical Trials Chicago Illinois 60614
AMR Convention Research Warrenville Illinois 60555
Benchmark Research Shreveport Louisiana 71101
Cenexel CBH (CBH Health) Gaithersburg Maryland 20877
Copley Clinical Boston Massachusetts 02116
Boston Clinical Trials Roslindale Massachusetts 02131
Adams Clinical Watertown Massachusetts 02471
Vitalix Clinical Worcester Massachusetts 01608
Neurobehavioral Medicine Group Bloomfield Hills Michigan 48302
Precise Research Centers Flowood Mississippi 39232
Center for Emotional Fitness Cherry Hill New Jersey 08002
Integrative Clinical Trials Brooklyn New York 11229
Basil Clinical Inwood New York 11096
Berman Clinical New York New York 10029
Manhattan Behavioral Medicine PLLC New York New York 10036
The Medical Research Network, LLC New York New York 10128
Patient Priority Clinical Studies LLC Cincinnati Ohio 45215
The Ohio State University Columbus Ohio 43210
Sooner Clinical Research Oklahoma City Oklahoma 73116
Suburban Research Associates West Chester Pennsylvania 19380
Clinical Neuroscience Solutions Inc. Memphis Tennessee 38119
Donald J. Garcia, Jr., MD, PA Austin Texas 78737
Community Clinical Research, Inc. Austin Texas 78754
FutureSearch Trials of Dallas Dallas Texas 75251
North Texas Clinical Trials Fort Worth Texas 76104
DM Clinical Research - Belliare Houston Texas 77081
Psychiatric And Behavioral Solutions, LLC Millcreek Utah 84124
Core Clinical Research Everett Washington 98201

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 24 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05593029, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 17, 2026 · Synced Sep 1, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05593029 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →